Dr Geoff Lawton was formerly the Vice President Chemistry and Preclinical Sciences at Roche Bioscience, Palo Alto, California and has extensive experience of new medicine discovery and early development. In 2001 he became an independent consultant in all aspects of drug discovery from target identification, through lead finding and optimisation to drug candidate selection and evaluation. He is currently Research Director at Lectus Therapeutics.